Clinical Pediatric Emergency Medicine
Volume 8, Issue 2 , Pages 117-122 , June 2007

Pediatric HIV in the Emergency Department

  • Joseph A. Church, MD

      Affiliations

    • Corresponding Author InformationReprint requests and correspondence: Joseph A. Church, MD, Keck School of Medicine, University of Southern California, 4650 Sunset Boulevard, Mail Stop #75, Los Angeles, CA 90027.

References 

  1. Centers for Disease Control and Prevention . Reduction in perinatal transmission of HIV infection—United States, 1985-2005. MMWR. 2006;55:592–597
  2. Center for Disease Control and Prevention . 1994 revised classification system for human immunodeficiency virus infections in children less than 13 years of age. MMWR. 1994;43:1–10
  3. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. 1993;328:327–335
  4. Church JA. Human immunodeficiency infection. In:  Osborn LM,  DeWitt FG,  First LR,  Zenel JA editor. Pediatrics. Philadelphia (Pa): Elsevier Mosby; 2005;p. 1132–1140
  5. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus infection. N Engl J Med. 1989;321:1791–1796
  6. In:  Ziechner SL,  Read JS editor. Textbook of pediatric HIV care. Cambridge (UK): Cambridge University Press; 2005;
  7. Wesolowski LG, Mackellar DA, Facente SN, et al. Post-marketing surveillance of OroQuick whole blood and oral fluid rapid HIV testing. AIDS. 2006;20:1661–1666
  8. Lambert JS, Harris R, Stiehm ER, et al. Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for the early diagnosis of perinatal HIV-1 infection. J Acquir Immune Defic Syndr. 2003;34:512–519
  9. U.S. Department of Health and Human Services . Pediatric antiretroviral human services: pediatric antiretroviral drug information. Available at: www.aidsinfo.nih.gov[Accessed 4/4/07]
  10. Centers for Disease Control and Prevention . Updated U.S. public health service guidelines for management of occupational exposures to HIV: recommendations for postexposure prophylaxis. MMWR. 2005;54:1–17
  11. Centers for Disease Control and Prevention . Antiretroviral postexposure prophylaxis after sexual injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR. 2005;54:1–20

PII: S1522-8401(07)00028-6

doi: 10.1016/j.cpem.2007.06.001

Clinical Pediatric Emergency Medicine
Volume 8, Issue 2 , Pages 117-122 , June 2007